Table 2 Clinical characteristics of the schizophrenia patients. Numbers are means ± standard deviation or medians (interquartile range)
Diagnosis, ICD-10 | |
|---|---|
Paranoid schizophrenia | 55% |
Undifferentiated schizophrenia | 28% |
Hebephrenic schizophrenia | 12% |
Unspecified schizophrenia | 5% |
Disease course | |
Age of onset (years) | 23.0 ± 5.3 |
Duration of illness (months) | 76 (36–189) |
Number of admissions | 3 (1–6) |
In-patient at inclusion | 60% |
Medication a | |
Duration of current antipsychotic treatment (months) | 20 (3–68) |
Number of antipsychotics used | |
One | 77% |
Two or three | 23% |
Antipsychotics, Defined Daily Doseb | 1.5 (0.7–2.3) |
Antidepressant use | 43% |
If antidepressant use, Defined Daily Dose | 1.4 (1.0–2.0) |
Benzodiazepine use | 28% |
If benzodiazepine use, Defined Daily Dose | 0.6 (0.3–1.2) |
Psychopathology | |
PANSS positive score | 22.2 ± 4.3 |
PANSS negative score | 22.3 ± 5.6 |
PANSS general score | 44.6 ± 8.5 |
PANSS total score | 89.1 ± 16.5 |